4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000124
Chief Medical Officer sold 7,866 shares at $37.69 ($296,470)
- Chief Medical Officer acquired 7,866 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,866 | $25.01 | $196,729 | 62,511 | D |
| 2026-10-26 | Sale : show line 2 in the form 10b5-1 | −7,866 | $37.69 | $296,470 | 54,645 | D |
| Open-market sales · 7,866 sh · avg $37.69 · $296,470 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-26 | Exercise or conversion : show line 3 in the form 10b5-1 Stock options (right to buy) | −7,866 | 16,275 | D |
Loading xslF345X06/wk-form4_1793217741.xml…